Joseph Perekupka is the CEO of Freespira, the only company to offer a medication-free, FDA-cleared digital therapeutic treatment proven to reduce or eliminate symptoms of panic disorder, panic attacks and PTSD in 28 days. Joe is a proven healthcare leader with over 25 years of commercial experience in multiple leadership and functional medical device and digital health roles. He plays an active role with organizations such as the Digital Therapeutics Alliance and DTx societies, where he maintains co-chair roles that are focused on propelling the DTx industry growth, and is passionate about creating equitable access to care for mental health patients nationwide.
Effective diabetes management requires a shift from focusing purely on blood sugar levels and weight management medications to embracing the psychological and biological contributors that drive obesity and the disease.
Providers should incorporate mental health screenings as a standard part of cancer care for patients and their loved ones.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
A CEO and father of two reflects on the Surgeon General's recent advisory, evolving pressures on today's parents and the impact on mental health.
If enacted, the codes will represent the first major step toward broad-based reimbursement for digital therapeutics, and acknowledgement that CMS recognizes the substantial role new digital solutions can provide.
In our eagerness for innovation, there's a risk that we ignore existing effective, readily-available treatments.